COVID-19 Vaccine, Testing, Resources & Visitor Policy Updates
Not Feeling Well? Check Your Symptoms with the New Online Symptom Checker.
  • MYCHART LOGIN PAY MY BILL FIND A DOCTOR FIND A LOCATION PATIENTS & VISITORS MEDICAL SERVICES COMMUNITY OUTREACH RESOURCES CAREERS CONTACT US
  • Patients & Visitors
  • Medical Services
  • Community Outreach
  • Resources
  • Careers
MYCHART LOGIN PAY MY BILL FIND A DOCTOR FIND A LOCATION PATIENTS & VISITORS MEDICAL SERVICES COMMUNITY OUTREACH RESOURCES CAREERS CONTACT US
  • Homepage
  • HealthLibrary
  • FAQ
Menu
  • Healthy Lifestyle
  • Diseases & Conditions
  • First Aid
  • Symptoms
  • Tests & Procedures
  • Videos
  • Definitions
  • FAQs

Osteoporosis: How long must I take bisphosphonates?

How long must I take bisphosphonates for osteoporosis? Are they a lifelong commitment?

Updated: 2021-07-10


Answer Section

Bisphosphonates, the most common type of osteoporosis medications, are typically taken for at least 3 to 5 years. After that, your doctor will consider your risk factors in determining whether you should continue to take these or other osteoporosis medications.

Examples of bisphosphonates include:

  • Alendronate (Binosto, Fosamax)
  • Ibandronate (Boniva)
  • Risedronate (Actonel, Atelvia)
  • Zoledronic acid (Reclast, Zometa)

These drugs help strengthen bones and prevent fractures. The most common sites for osteoporosis fractures are the wrist, hip and spine. A broken hip can result in a severe decline in quality of life and even increases the risk of death.

Rarely, bisphosphonates may cause:

  • Osteonecrosis of the jaw. This bone disease features pain, swelling or infection in the jaw. This occurs most commonly after invasive dental procedures, such as tooth extractions.
  • Thighbone fractures. Long-term bisphosphonate therapy has been linked to a rare type of thigh fracture. This injury, known as atypical femoral fracture, is similar to a stress fracture, causing pain that begins subtly and can gradually worsen. If not identified early on, a complete fracture of the thighbone can occur.

To reduce the risk of these rare complications, your doctor may recommend that you temporarily stop taking bisphosphonates after 3 to 5 years. This is sometimes called a bisphosphonate holiday. People who have severe osteoporosis may need to wait for 10 years before they stop taking these drugs.

A bisphosphonate holiday typically lasts at least a year, but it may last indefinitely for some people if the risks of treatment outweigh the benefits. Luckily, the bone-strengthening effects of bisphosphonates appear to continue for several years after people stop taking the drugs.


Content from Mayo Clinic
© 1998-2022 Mayo Foundation for Medical Education and Research(MFMER). All rights reserved. Terms of Use
About St. Elizabeth
  • About Us
  • Associate Log In
  • Associate Intranet
  • Careers
  • For Health Professionals
  • Foundation
  • St. Elizabeth Physicians
  • Learn More
How Can We Help?
  • Find a Location
  • Find a Provider
  • Frequently Called Numbers
  • Health Library
  • Pay My Bill
  • Pagar Su Factura
  • Site Map
Legal
  • Disclaimer/HIPAA
  • Patient Rights and Responsibilities
  • © 2019 St. Elizabeth Healthcare.
  • All rights reserved. St. Elizabeth Healthcare is a registered 501(c)(3) non-profit corporation serving the Northern Kentucky/Greater Cincinnati region. Tax identification #610445850
Help Us Continue To Provide Quality Care
  • Donate
  • Human Resources
  • Physician Opportunities
  • Volunteer
Visit St. Elizabeth Physicians
Healthy
Headlines
  • Helping you live a better life.
  • View Health Tips
Social
About St. Elizabeth
About Us
Associate Log In
Associate Intranet
Careers
For Health Professionals
Foundation & Donations
Volunteers
Resources
CareGram
Find a Location
Find a Provider
Frequently Called Numbers
MyChart Login
Pay My Bill
Legal
Disclaimer/HIPAA
Patient Rights and Responsibilities
Human Resources
© 2022 St. Elizabeth Healthcare. All rights reserved. St. Elizabeth Healthcare is a registered 501(c)(3) non-profit corporation serving the Northern Kentucky/Greater Cincinnati region. Tax identification #610445850